Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: JAMA Psychiatry. 2015 Oct;72(10):1012–1020. doi: 10.1001/jamapsychiatry.2015.1154

Table.

Baseline Characteristics of Randomized Participants

Characteristic No. (%)
Total
(n = 141)
CBT-T
(n = 70)
NST-T
(n = 71)
Sex
  Male 26 (18.4) 12 (17.1) 14 (19.7)
  Female 115 (81.6) 58 (82.9) 57 (80.3)
Race/ethnicity
  African American 8 (5.7) 4 (5.7) 4 (5.6)
  White 128 (90.8) 64 (91.4) 64 (90.1)
  Other 5 (3.5) 2 (2.9) 3 (4.2)
Age, y
  60–64 66 (46.8) 29 (41.4) 37 (52.1)
  65–69 38 (27.0) 20 (28.6) 18 (25.4)
  70–74 19 (13.5) 8 (11.4) 11 (15.5)
  ≥75 18 (12.8) 13 (18.6) 5 (7.0)
Education
  Less than high school 7 (5.0) 4 (5.7) 3 (4.2)
  High school grad or GED 18 (12.8) 9 (12.9) 9 (12.7)
  Some college 53 (37.6) 19 (27.1) 34 (47.9)
  College degree 63 (44.7) 38 (54.3) 25 (35.2)
Income, $
  ≤24 999 33 (23.4) 12 (17.1) 21 (29.6)
  25 000–49 999 41 (29.1) 21 (30.0) 20 (28.2)
  50 000–74 999 19 (13.5) 10 (14.3) 9 (12.7)
  ≥75 000 16 (11.4) 7 (10.0) 9 (12.7)
  Missing 32 (22.7) 20 (28.6) 12 (16.9)
Marital status
  Never been married 1 (0.7) 1 (1.4) 0 (0.0)
  Married or living with someone 75 (53.2) 37 (52.9) 38 (53.5)
  Divorced 27 (19.2) 13 (18.6) 14 (19.7)
  Separated 9 (6.4) 4 (5.7) 5 (7.0)
  Widowed 29 (20.6) 15 (21.4) 14 (19.7)
  Currently employed 38 (27.0) 17 (24.3) 21 (29.6)
Living status
  With others 87 (61.7) 41 (58.6) 46 (64.8)
  Alone 54 (38.3) 29 (41.4) 25 (35.2)
Smoking status
  Never 68 (48.2) 37 (52.9) 31 (43.7)
  Current 14 (9.9) 6 (8.6) 8 (11.3)
  Former 59 (41.8) 27 (38.6) 32 (45.1)
Current psychotropic medication usage
  Anxiolytics 38 (27.0) 22 (31.4) 16 (22.5)
  Hypnotics 12 (8.5) 5 (7.1) 7 (9.9)
  Antidepressants 54 (38.3) 29 (41.4) 25 (35.2)
  Antipsychotics/neuroleptics 3 (2.1) 1 (1.4) 2 (2.8)
  Stimulants 1 (0.7) 0 (0.0) 1 (1.4)
History of self-reported health problems
  Hypertension 92 (65.7) 43 (62.3) 49 (69.0)
  Myocardial infarction 9 (6.4) 4 (5.8) 5 (7.0)
  Congestive heart failure 8 (5.7) 4 (5.7) 4 (5.6)
  Stroke 11 (7.9) 5 (7.2) 6 (8.5)
  Diabetes mellitus 29 (20.6) 9 (12.9) 20 (28.2)
Score, mean (SD)
  TICS-m 36.9 (4.6) 36.7 (4.5) 37.2 (4.6)
  PSWQA 31.0 (5.57) 30.6 (5.53) 31.4 (5.62)
  HAMA 21.0 (7.70) 20.1 (7.14) 21.9 (8.18)
  BDI 23.0 (9.08) 21.6 (8.84) 24.4 (9.18)
  GAD-7 11.7 (4.29) 11.1 (4.25) 12.3 (4.28)
Presence of comorbid depression diagnosis
  Total 102 (72.3) 51 (72.9) 51 (71.8)
  Current 54 (38.3) 23 (32.9) 31 (43.7)
  Past 48 (34.0) 28 (40.0) 20 (28.2)
Presence of comorbid anxiety diagnosis 72 (51.1) 31 (44.3) 41 (57.8)

Abbreviations: BDI, Beck Depression Inventory; CBT-T, telephone-delivered cognitive behavioral therapy; GAD, generalized anxiety disorder; GAD-7, Generalized Anxiety Disorder Scale 7 Item; GED, general educational development test; HAMA, Hamilton Anxiety Rating Scale; NST-T, telephone-delivered nondirective supportive therapy; PSWQ-A, Penn State Worry Questionnaire–Abbreviated; TICS-m, Telephone Interview for Cognitive Status–Modified.